The antiviral, Daclatasvir, downregulates Tribbles 2 pseudokinase and reverses enzalutamide resistance in prostate cancer

被引：0
|
作者：
Monga, Jitender
Guddeti, Rohith
Rogers, Craig
Gadgeel, Shirish
Chitale, Dhananjay
Ghosh, Jagadananda
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4751
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells
    Monga, Jitender
    Valeriote, Frederick
    Hwang, Clara
    Gadgeel, Shirish
    Ghosh, Jagadananda
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (03) : 381 - 392
  • [2] Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity
    Monga, Jitender
    Adrianto, Indra
    Rogers, Craig
    Gadgeel, Shirish
    Chitale, Dhananjay
    Alumkal, Joshi J.
    Beltran, Himisha
    Zoubeidi, Amina
    Ghosh, Jagadananda
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (02)
  • [3] Overexpression of Tribbles 2 enhances prostate cancer cell growth and contributes to enzalutamide resistance.
    Monga, Jitender
    Sanghvi, Parshva
    Ghosh, Jagadananda
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Inhibition of Rac1 reverses enzalutamide resistance in castration-resistant prostate cancer
    Chen, Xiaoliang
    Yin, Lili
    Qiao, Gan
    Li, Yanhua
    Li, Baoyuan
    Bai, Yunfeng
    Feng, Feng
    ONCOLOGY LETTERS, 2020, 20 (03) : 2997 - 3005
  • [5] Emerging mechanisms of enzalutamide resistance in prostate cancer
    Claessens, Frank
    Helsen, Christine
    Prekovic, Stefan
    Van den Broeck, Thomas
    Spans, Lien
    Van Poppel, Hendrik
    Joniau, Steven
    NATURE REVIEWS UROLOGY, 2014, 11 (12) : 712 - 716
  • [6] Emerging mechanisms of enzalutamide resistance in prostate cancer
    Frank Claessens
    Christine Helsen
    Stefan Prekovic
    Thomas Van den Broeck
    Lien Spans
    Hendrik Van Poppel
    Steven Joniau
    Nature Reviews Urology, 2014, 11 : 712 - 716
  • [7] Mitophagy imparts enzalutamide resistance in prostate cancer
    Basu, Hirak S.
    Schrieber, Cynthia L.
    Sperger, Jamie M.
    Naundorf, Maryanne
    Weichman, Ashley M.
    Mehraein-Ghomi, Farideh
    Church, Dawn R.
    Lang, Joshua M.
    Wilding, George
    CANCER RESEARCH, 2015, 75
  • [8] Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
    Zoran Culig
    Current Molecular Biology Reports, 2017, 3 (4) : 230 - 235
  • [9] Molecular mechanisms of enzalutamide resistance in prostate cancer
    Blatt, Eliot B.
    Raj, Ganesh, V
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 189 - 197
  • [10] PROSTATE CANCER Fitting to overcome enzalutamide resistance
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (10) : 564 - +
12345